Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06617832Recruiting
Evaluating migraine treatment designs
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
Aarhus CAges 18–65 - NCT06611007RecruitingPhase 1/Phase 2
Lipiodol injections for painful finger arthritis not helped by usual treatments
This trial tests if injecting a special dye (Lipiodol) into the blood vessels of the fingers can safely reduce pain and symptoms in people with hand osteoarthritis that hasn't responded to standard pain relievers.
ÉchirollesAges 40 years+ - NCT06471413Recruiting
Testing a violence prevention program in middle schools
This trial tests a program called BOAT® to reduce violence in middle schools. It looks at how the program affects students and school staff.
MontpellierAges 13–17 - NCT03850574RecruitingPhase 1/Phase 2
Tuspetinib for relapsed or hard-to-treat AML
This early-phase study tests tuspetinib in people with AML that has come back or did not respond to treatment. The goal is to learn whether it is safe and tolerable, how the drug behaves in the body, and whether it shows signs of benefit.
Birmingham, AlabamaAges 18 years+ - NCT06585787RecruitingPhase 3
Testing KarXT for psychosis in Alzheimer’s disease
This study tests an investigational medication (KarXT) for treating psychosis—hallucinations or delusions—in people with Alzheimer’s disease. It aims to see if the drug can reduce these symptoms safely and effectively.
Chandler, ArizonaAges 55–90 - NCT06600321RecruitingPhase 1
Study of ALN-BCAT for liver cancer
This trial tests a new drug called ALN-BCAT for people with advanced liver cancer (hepatocellular carcinoma) that has a specific genetic change. If you have already tried at least one treatment, this study may be an option for you.
Phoenix, ArizonaAges 18 years+ - NCT06597006RecruitingPhase 3
Study of inclisiran for children with homozygous familial high cholesterol
This trial tests a new medicine called inclisiran to lower very high cholesterol in children aged 2 to 12 who have a specific genetic condition (homozygous familial hypercholesterolemia, or HoFH). You may not need to change your current cholesterol treatments, and the study will check if inclisiran can help reduce your LDL cholesterol further.
San Francisco, CaliforniaAges 2–11 - NCT06598319Recruiting
Pulsed field ablation for chronic rhinitis
This trial tests a new treatment that uses pulsed energy to target a nerve in the back of the nose to help with chronic rhinitis (long-term runny or stuffy nose). It is for people whose symptoms have not been controlled by nasal steroid sprays.
Colorado Springs, ColoradoAges 18–85 - NCT06585774RecruitingPhase 3
Axatilimab plus steroids for new chronic GVHD
This study tests a new drug called axatilimab combined with steroids as a first treatment for chronic graft-versus-host disease (GVHD) after a stem cell transplant. It aims to see if this combination helps control symptoms better than steroids alone.
Birmingham, AlabamaAges 12 years+ - NCT06597019RecruitingPhase 3
Study of inclisiran for children with high cholesterol
This trial tests a medicine called inclisiran to lower high cholesterol in children ages 6 to 12 with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). It may help children who still have high cholesterol despite taking other treatments.
San Francisco, CaliforniaAges 6–11 - NCT06585449RecruitingPhase 1
Study of ALN-HTT02 for Huntington's disease
This trial tests an experimental drug called ALN-HTT02 for people with Huntington's disease. The goal is to see if it can help manage symptoms. Participants must have stage 2 or early stage 3 Huntington's disease.
EdmontonAges 25–70 - NCT06600412RecruitingPhase 2
Testing R3R01 for protein in urine from diabetic kidney disease
This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.
Copenhagen, CopenhagenAges 18 years+ - NCT06588478RecruitingPhase 2
Study of pirtobrutinib for CLL or SLL
This trial tests a new drug called pirtobrutinib for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is for those whose cancer has come back or not responded to treatment, including a prior BTK inhibitor, and also for those who have never been treated but have a specific genetic change (17p deletion).
Chandler, ArizonaAges 18 years+ - NCT06586905Recruiting
A study of a new syphilis test at an Ottawa sexual health clinic
This study tests a new rapid syphilis test (Multiplo® Complete Syphilis) that can be done at a clinic. It aims to see how well it detects infectious syphilis compared to standard lab tests. You might help if you are getting syphilis testing at the clinic.
Ottawa, OntarioAges 16 years+ - NCT06593977Recruiting
Dynavisc gel for pain after repeat carpal tunnel surgery
This trial tests a gel called Dynavisc to see if it reduces pain when placed in the wrist during a second surgery for carpal tunnel syndrome. It may help people who still have pain after their first surgery.
Leuven, BelgiumAges 18–65 - NCT06588803Enrolling by invitation
Long-term follow-up after EXG001-307 for type 1 SMA
This study follows up on patients with type 1 spinal muscular atrophy (SMA) who already received the EXG001-307 gene therapy in a previous trial. The goal is to monitor their long-term health and safety over time.
Shanghai, Shanghai MunicipalityAges 1 month+ - NCT06591780Recruiting
Biofeedback to improve walking for diabetic nerve damage
This study tests a special biofeedback system to help people with diabetic nerve damage walk better. You'll use sensors during treadmill walking to see if real-time feedback can improve your stride and balance.
Pensacola, FloridaAges 45–90 - NCT06588621Recruiting
Health of healthcare workers: a Paris hospital study
This trial studies the health of healthcare workers in training (residents) at seven Paris hospitals. It aims to evaluate their well-being through a short, anonymous survey.
Paris, IDFAges 18 years+ - NCT06587529Recruiting
Preventing exploitation of teens in Des Moines
This program teaches teens how to recognize and avoid situations involving exploitation or trafficking. It may help you feel safer and more informed about these risks.
Des Moines, IowaAges 13–19 - NCT06599879Recruiting
Brain radiation effects on memory and attention in kids
This study looks at how radiation from brain tumor treatment affects memory, attention, and thinking skills in children. It uses brain scans and tests to understand these effects.
AngersAges 6–14 - NCT06597305Enrolling by invitation
CBT for adults with anorexia nervosa
This trial tests a 20-session cognitive-behavioral therapy (CBT) designed specifically for adults with anorexia nervosa. You will attend regular therapy sessions and complete questionnaires to see if this treatment helps improve your eating habits and overall well-being.
Boston, MassachusettsAges 18 years+ - NCT06600295Recruiting
Taste changes and nutrition in new cancer patients
This study looks at how cancer and its treatments affect taste and nutrition. It aims to find ways to help patients maintain good nutrition during treatment.
DijonAges 18 years+ - NCT06597097Enrolling by invitation
Study of healthcare team collaboration with medical cannabis
This study looks at how healthcare professionals work together – between primary care doctors, hospital doctors, and pharmacists – during France’s medical cannabis experiment. It aims to see if teamwork improves care.
BrestAges 18 years+ - NCT06583525Enrolling by invitation
Testing the TAC Program for teens with complex health needs
This study tests a program called TAC that helps teens with complex health needs move from SickKids to adult health care. It's for 16- to 18-year-olds who have multiple long-term conditions or a rare disease and might need extra support during this big change.
Toronto, OntarioAges 16–18
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.